Document Detail


Clinical and pathobiologic considerations in the evaluation of markers of myocardial ischemia.
MedLine Citation:
PMID:  12213985     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is a need for blood-based analytic techniques that allow for the detection of patients either with reversible myocardial ischemia or who are at risk for myocardial ischemia. However, given the diverse etiologies of unstable angina and the complex interactions among various cell types, the term "marker for ischemia" should be used with caution (if at all). Unless we find a protein that is released across the diverse pathologic triggers associated with the various stages of progression of atherosclerosis and cellular ischemia, we will be forced to consider a spectrum of proteins (and analytic assays) that are situationally specific. The choice of an appropriate gold standard as we investigate the clinical application of these assays will be one of the most difficult and most important decisions in these studies. It will be critical that conclusions of usefulness in one setting of ischemic heart disease not be generalized in the absence of clinical trials supporting that contention.
Authors:
J E Adams
Related Documents :
9284845 - Intravenous immunoglobulin, blood viscosity and myocardial infarction.
1535185 - The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anes...
3261305 - Comparison of coronary artery bypass surgery and medical therapy in patients with exerc...
23530485 - High-frequency qrs analysis in patients with acute myocardial infarction: a preliminary...
18544375 - Impact of left atrial volume reduction concomitant with atrial fibrillation surgery on ...
15897645 - Embolic stroke with a patent foramen ovale and behcet's disease.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiovascular toxicology     Volume:  1     ISSN:  1530-7905     ISO Abbreviation:  Cardiovasc. Toxicol.     Publication Date:  2001  
Date Detail:
Created Date:  2002-09-05     Completed Date:  2002-10-08     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  101135818     Medline TA:  Cardiovasc Toxicol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  135-9     Citation Subset:  IM    
Affiliation:
Jewish Hospital Heart and Lung Institute, Louisville KY 40202, USA. jadams03@sprynet.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / analysis*
Humans
Myocardial Ischemia / diagnosis*,  pathology*,  therapy
Necrosis
Chemical
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rationale for the early clinical application of markers of ischemia in patients with suspected acute...
Next Document:  Markers of platelet activation and thrombin generation.